OÜ Kopik

Active Registry code 12166622 OÜ Tartu linn Registered 26 Sep 2011
Compare

OÜ Kopik is a OÜ based in Tartu linn, registry code 12166622, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2019 0 €
    industry median 0 € · companies in the industry: 686

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 — — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — — —
Q3 2023 — 1 — —
Q2 2023 — — — —
Q1 2023 — — — —
Q4 2022 — — — —
Q3 2022 — — — —
Q2 2022 — — — —
Q1 2022 — — — —

Financials by year

2016 – 2025
Revenue, € 2019: 0 € · industry median 0 € · above 5% of the industry
0501001502016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 0 € Industry median: 0 €20192020 Company: — Industry median: 150 €20202021 Company: — Industry median: 0 €20212022 Company: — Industry median: 103 €20222023 Company: — Industry median: 76 €20232024 Company: — Industry median: 0 €20242025 Company: — Industry median: 0 €20250501001502018 Company: — Industry median: —2019 Company: 0 € Industry median: 0 €20192020 Company: — Industry median: 150 €2021 Company: — Industry median: 0 €20212022 Company: — Industry median: 103 €2023 Company: — Industry median: 76 €20232024 Company: — Industry median: 0 €2025 Company: — Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 70 € · +184.3% vs 2024 · industry median 0 € · above 56% of the industry
-5 00005 00010 00015 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 3 114 € Industry median: 3 €20192020 Company: 12 914 € Industry median: 28 €20202021 Company: 340 € Industry median: 1 €20212022 Company: 255 € Industry median: 0 €20222023 Company: -420 € Industry median: 0 €20232024 Company: -83 € Industry median: 0 €20242025 Company: 70 € Industry median: 0 €2025-5 00005 00010 00015 0002018 Company: — Industry median: —2019 Company: 3 114 € Industry median: 3 €20192020 Company: 12 914 € Industry median: 28 €2021 Company: 340 € Industry median: 1 €20212022 Company: 255 € Industry median: 0 €2023 Company: -420 € Industry median: 0 €20232024 Company: -83 € Industry median: 0 €2025 Company: 70 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 138 610 € · +0.1% vs 2024
0501001502016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 125 583 €20192020 Company: 138 464 €20202021 Company: 138 801 €20212022 Company: 139 095 €20222023 Company: 138 623 €20232024 Company: 138 540 €20242025 Company: 138 610 €20250501001502018 Company: —2019 Company: 125 583 €20192020 Company: 138 464 €2021 Company: 138 801 €20212022 Company: 139 095 €2023 Company: 138 623 €20232024 Company: 138 540 €2025 Company: 138 610 €2025
Equity, € thousand 2025: 138 610 € · +0.1% vs 2024
0501001502016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 125 534 €20192020 Company: 138 448 €20202021 Company: 138 788 €20212022 Company: 139 043 €20222023 Company: 138 623 €20232024 Company: 138 540 €20242025 Company: 138 610 €20250501001502018 Company: —2019 Company: 125 534 €20192020 Company: 138 448 €2021 Company: 138 788 €20212022 Company: 139 043 €2023 Company: 138 623 €20232024 Company: 138 540 €2025 Company: 138 610 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — 70 0 138 610 138 610 0
2024 — -83 0 138 540 138 540 0
2023 — -420 0 138 623 138 623 0
2022 — 255 0 139 095 139 043 0
2021 — 340 0 138 801 138 788 0
2020 — 12 914 0 138 464 138 448 0
2019 0 3 114 0 125 583 125 534 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0
2014 — — — — — 1
2013 — — — — — 1
2012 — — — — — 1
2011 — — — — — 1

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
0.1 %
Net profit / equity
Return on assets (ROA)
0.1 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 25 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 28 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 25 Sep 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 14 Dec 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 21 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 10 Jul 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

  • Elen Lepik
    Direct ownership · since 30 Oct 2018

Founders and other persons

  • Elen Lepik
    Founder · 2 500 € · 24 Sep 2011

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 10160534 / 9
30 Jun 2025
Amendment entry In force
30 Jun 2025
PDF
Ä 10160534 / 8
3 Sep 2023
Amendment entry In force
3 Sep 2023
PDF
Ä 10160534 / 7
15 Dec 2021
Amendment entry In force
15 Dec 2021
PDF
Ä 10160534 / 6
27 Jun 2019
Amendment under Commercial Code § 525 (2) In force
27 Jun 2019
PDF
Ä 10160534 / 5
17 Jan 2018
Amendment entry In force
17 Jan 2018
PDF
Ä 10160534 / 4
2 Dec 2017
Amendment entry In force
2 Dec 2017
PDF
Ä 10160534 / 3
29 Feb 2016
Amendment under Commercial Code § 525 (2) In force
29 Feb 2016
PDF
Ä 10160534 / 2
22 Oct 2012
Amendment under Commercial Code § 525 (2) In force
22 Oct 2012
PDF
Ä 10160534
26 Sep 2011
First entry In force
26 Sep 2011
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data